If, not when. This isn't fantasy, it's the equity of a development state biotech, and "mouse(murine)" trials are not disease. Pumping and bashing can mislead others, especially if they're inexperienced. Ignore nonsense; there's a lot of it.
You are making it personal. Whether I "like" a CEO is irrelevant. My post had nothing to do with "likeability" at all. What it had to with was execution as a DRUG COMPANY CEO. He has not demonstrated any ability to do that. He can't get trial results right, how can anyone expect him to get a drug to market - that's a lot of execution.
I am making a distinction between an operating CEO and a financial CEO so don't come at me with he's raised a bunch of money, been smart with his spend, etc. That doesn't matter now. Only operational execution.
News 
Market Data 
Discover 
AI
